Glucose Control with Sitagliptin Phosphate
Sitagliptin generic phosphate (Januvia, Merck), the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors, enhances the body’s own ability to lower elevated blood glucose levels.
The FDA approved the tablets for use in addition to diet and exercise to improve blood sugar levels in patients with type-2 diabetes; the drug [...]
Read User's Comments